Precise cut-and-paste DNA insertion using engineered type V-K CRISPR-associated transposases
Your Content Goes Here Genome editing technologies capable [...]
About CGM Admin
This author has not yet filled in any details.So far CGM Admin has created 96 blog entries.
Seven technologies to watch in 2023: CRISPR anywhere
Your Content Goes Here Nature picks the top [...]
Beyond BMI to estimate disease risk
Your Content Goes Here People with the same [...]
Huntingtin turnover: modulation of huntingtin degradation by cAMP-dependent protein kinase A (PKA) phosphorylation of C-HEAT domain Ser2550
Your Content Goes Here Huntington's disease (HD) is [...]
Long-term effects of l-serine supplementation upon a mouse model of diabetic neuropathy
Your Content Goes Here Deoxysphingolipids (1-deoxySLs) are neurotoxic [...]
Heterozygous mutations in SOX2 may cause idiopathic hypogonadotropic hypogonadism via dominant-negative mechanisms
Your Content Goes Here Pathogenic SRY-box transcription factor [...]
Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma
Your Content Goes Here Neurofibromatosis 2 (NF2) is [...]
CHIPping away at cardiovascular disease
Your Content Goes Here Clonal hematopoiesis of indeterminate [...]
Analysis of genetic dominance in the UK Biobank
Your Content Goes Here For many monogenic traits, [...]
Diverse data expand what’s known about IBD genetics
Your Content Goes Here Inflammatory bowel diseases (IBDs) [...]
The Center for Genomic Medicine (CGM) comprises one of the largest and most vibrant hubs of genomic medicine research in the world. The CGM includes 46 faculty collaborating to define the ‘genomic medicine cycle’ – which envisages a genomics community seeking to advance research from basic genomics research to ultimately using genome information for diagnostics and targeted therapeutics. All of our investigators are faculty at Harvard Medical School, and many members of our community are also investigators at the Broad Institute of Harvard and MIT.
